Companies › NXL

NEXALIN TECHNOLOGY INC (NXL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001527352 · EDGAR filings · Updated 2026-07-27

NEXALIN TECHNOLOGY INC (NXL) has reported institutional ownership of 5.1%, with 22 institutional managers holding positions valued at $370.1K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-10 — ARS filed
• 2026-07-10 — Proxy statement (DEF 14A) filed
• 2026-06-29 — PRE 14A filed
• 2026-06-17 — Current report (8-K) filed
• 2026-05-19 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEXALIN TECHNOLOGY INC has 22 institutional holders and institutional ownership of 5.1%.

Insider activity

Insiders reported 4 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

PMGC HLDGS INC (ELAB) · Theriva Biologics Inc (TOVX) · SILO PHARMA INC (SILO) · MUSTANG BIO INC (MBIO) · ACLARION INC (ACON) · Aspire Biopharma Holdings Inc (ASBP)